NIH Guide: Weekly Index for August 19, 2022

Funding Opportunities

• AHRQ Conference Grant Programs (R13)
  (PA-22-238)
  Agency for Healthcare Research and Quality
  Application Receipt Date(s): October 31, 2026
• Integrative Research to Understand the Impact of Sex Differences on the Molecular Determinants of AD Risk and Responsiveness to Treatment (U01 Clinical Trial Optional)
  (PAR-22-228)
  National Institute on Aging
  Application Receipt Date(s): February 21, 2023
• Laboratory of Developmental Biology (R24 Clinical Trial Not Allowed)
  (PAR-22-229)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute of Allergy and Infectious Diseases
  National Institute of Mental Health
  Application Receipt Date(s): November 2, 2022
• Javits Neuroscience Investigator Award Extension Request (Type 4 Clinical Trial Optional)
  (PAR-23-022)
  National Institute of Neurological Disorders and Stroke
  Application Receipt Date(s): The earliest Application Due Date is September 15, 2022 NINDS Javits award Phase 2 requests are due sixty days prior to the end of the initial phase budget period. Recipients are encouraged to contact the NINDS program director and grants management specialist assigned to the R37 award for details. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Fostering Mental, Emotional, and Behavioral (MEB) Health Among Children in School Settings: Opportunities for Multisite Trials of Complementary and Integrative Health Interventions (Clinical Trial Optional)
  (RFA-AT-23-003)
  National Center for Complementary and Integrative Health
  Office of Disease Prevention
  Application Receipt Date(s): October 28, 2022
• Research Resource Center to Build an Open-Access Repository and Database for Anatomical and Physiological Correlates of Acupoints (U24, Clinical Trial Optional)
  (RFA-AT-23-005)
  National Center for Complementary and Integrative Health
  Application Receipt Date(s): November 30, 2022
• Consortium on Translational Research in Early Detection of Liver Cancer: Translational Research Centers (U01 Clinical Trial Optional)
  (RFA-CA-22-031)
  National Cancer Institute
  Application Receipt Date(s): November 7, 2022
• Consortium on Translational Research in Early Detection of Liver Cancer: Data Management and Coordinating Center (U24 Clinical Trial Not Allowed)
  (RFA-CA-22-032)
  National Cancer Institute
  Application Receipt Date(s): November 7, 2022
• The NCI Predoctoral to Postdoctoral Fellow Transition Award (F99/K00 Clinical Trial Not Allowed)
  (RFA-CA-22-041)
  National Cancer Institute
  Application Receipt Date(s): November 18, 2022
• Radiation Oncology-Biology Integration Network (ROBIN) Centers (U54 Clinical Trial Required)
  (RFA-CA-22-046)
  National Cancer Institute
  Application Receipt Date(s): October 3, 2022
• The Early Detection Research Network: Clinical Validation Centers (U01 Clinical Trial Optional)
  (RFA-CA-22-054)
  National Cancer Institute
  Application Receipt Date(s): September 19, 2022
• HEAL Initiative: Development and validation of virtual assessments to study children and caregivers in their natural environment (R01- Clinical Trial Not Allowed)
  (RFA-DA-23-050)
  National Institute on Drug Abuse
  National Institute on Alcohol Abuse and Alcoholism
  National Center for Complementary and Integrative Health
  Application Receipt Date(s): February 3, 2023
• HEAL Initiative: Development and validation of virtual assessments to study children and caregivers in their natural environment (R01- Basic Experimental Studies with Humans Required)
  (RFA-DA-23-055)
  National Institute on Drug Abuse
  National Institute on Alcohol Abuse and Alcoholism
  National Center for Complementary and Integrative Health
  Application Receipt Date(s): February 7, 2023
• Chemical Countermeasures Research Program (CCRP) Initiative: Basic Research on The Deleterious Effects of Acute Exposure to Ultra-Potent Synthetic (UPS) Opioids (R01 Clinical Trial Not Allowed)
  (RFA-DA-23-056)
  National Institute on Drug Abuse
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): November 19, 2024
• Practice-Based Research Integrating Multidisciplinary Experiences in Dental Schools (PRIMED) (U01 Clinical Trial Not Allowed)
  (RFA-DE-23-012)
  National Institute of Dental and Craniofacial Research
  Application Receipt Date(s): February 24, 2023
• MPRINT Translational Research Resource Platform (TRRP) (U24 Clinical Trial Not Allowed)
  (RFA-HD-23-018)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  Application Receipt Date(s): December 01, 2022
• Training Award to Promote Cross-Training in the Fields of Traumatic Brain Injury (TBI) as a Risk Factor for Alzheimers Disease/Alzheimers Disease Related Dementias (AD/ADRD) (K18 Clinical Trial Not Allowed)
  (RFA-NS-22-061)
  National Institute of Neurological Disorders and Stroke
  National Institute on Aging
  Application Receipt Date(s): November 4, 2022